Log in to save to my catalogue

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_500448

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this randomized trial involving 13,885 patients with symptomatic peripheral artery disease (PAD), ticagrelor was not shown to be superior to clopidogrel for the reduction of cardiovascular events. Major bleeding occurred at similar rates with ticagrelor and clopidogrel.
Peripheral artery disease is considered to be a clinical manifestation of...

Alternative Titles

Full title

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_500448

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_500448

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1611688

How to access this item